$53.39
0.30% yesterday
Nasdaq, Nov 25, 10:01 pm CET
ISIN
US46266A1097
Symbol
IRMD

iRadimed Corp Stock price

$53.39
+3.00 5.95% 1M
+11.01 25.98% 6M
+5.92 12.47% YTD
+12.55 30.72% 1Y
+12.94 31.97% 3Y
+31.79 147.17% 5Y
+45.03 538.35% 10Y
Nasdaq, Closing price Mon, Nov 25 2024
+0.16 0.30%
ISIN
US46266A1097
Symbol
IRMD
Sector

Key metrics

Market capitalization $676.63m
Enterprise Value $625.17m
P/E (TTM) P/E ratio 36.57
EV/FCF (TTM) EV/FCF 35.12
EV/Sales (TTM) EV/Sales 8.77
P/S ratio (TTM) P/S ratio 9.49
P/B ratio (TTM) P/B ratio 8.11
Dividend yield 0.00%
Last dividend (FY22) $0.96
Revenue growth (TTM) Revenue growth 13.23%
Revenue (TTM) Revenue $71.31m
EBIT (operating result TTM) EBIT $21.32m
Free Cash Flow (TTM) Free Cash Flow $17.80m
Cash position $51.72m
EPS (TTM) EPS $1.46
P/E forward 35.48
P/S forward 9.29
EV/Sales forward 8.59
Short interest 1.01%
Show more

Is iRadimed Corp a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.

iRadimed Corp Stock Analysis

Unlock Scores for Free

Analyst Opinions

2 Analysts have issued a iRadimed Corp forecast:

2x Buy
100%

Analyst Opinions

2 Analysts have issued a iRadimed Corp forecast:

Buy
100%

Financial data from iRadimed Corp

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
71 71
13% 13%
100%
- Direct Costs 16 16
9% 9%
23%
55 55
15% 15%
77%
- Selling and Administrative Expenses 27 27
6% 6%
38%
- Research and Development Expense 5.92 5.92
111% 111%
8%
22 22
12% 12%
31%
- Depreciation and Amortization 0.83 0.83
14% 14%
1%
EBIT (Operating Income) EBIT 21 21
11% 11%
30%
Net Profit 19 19
14% 14%
26%

In millions USD.

Don't miss a Thing! We will send you all news about iRadimed Corp directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

iRadimed Corp Stock News

Neutral
GlobeNewsWire
22 days ago
WINTER SPRINGS, Fla., Nov. 04, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD) was recently named one of Fortune's 100 Fastest Growing Companies for 2024. Iradimed is a leader in the development of innovative magnetic resonance imaging (“MRI”) medical devices and the only provider of a non-magnetic intravenous (“IV”) infusion pump system, and non-magnetic patient vi...
Neutral
Seeking Alpha
26 days ago
IRADIMED CORPORATION. (NASDAQ:IRMD ) Q3 2024 Earnings Conference Call October 31, 2024 11:00 AM ET Company Participants Roger Susi - President and Chief Executive Officer Jack Glenn - CFO Conference Call Participants Frank Takkinen - Lake Street Capital Markets Jason Wittes - ROTH Capital Partners Operator Welcome to the IRadimed Corporation Third Quarter of 2024 Financial Results Conference Call.
Neutral
GlobeNewsWire
26 days ago
WINTER SPRINGS, Fla., Oct. 31, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD) announced today its financial results for the three and nine months ended September 30, 2024. The Company is a leader in the development of innovative magnetic resonance imaging (“MRI”) medical devices and the only known provider of a non-magnetic intravenous (“IV”) infusion pump system, ...
More iRadimed Corp News

Company Profile

IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging (MRI) compatible medical devices and accessories and services. It also provides non-magnetic Intravenous (IV) infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.

Head office United States
CEO Roger Susi
Employees 148
Founded 1992
Website www.iradimed.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today